Rankings
▼
Calendar
NMRA FY 2020 Earnings — Neumora Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
NMRA
Neumora Therapeutics, Inc. Common Stock
$559M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$96M
Net Income
-$99M
EPS (Diluted)
$-0.65
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$28M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$198M
Total Liabilities
$292M
Stockholders' Equity
-$94M
Cash & Equivalents
$192M
← Q4 2020
All Quarters
